US Biopreservation Market

ID: MRFR/MED/13963-HCR
100 Pages
Rahul Gotadki
Last Updated: April 06, 2026
US Biopreservation Market Research Report: Size, Share, Trend Analysis By Applications (Cell and Tissue Culture, Gene and Drug Therapy, Clinical Applications, Regenerative Medicine), By Product Type (Biopreservation Media, Freezers, Cryogenic Storage Systems, Accessories), By End Users (Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Hospitals, Clinics) and By Storage Type (Cryopreservation, Controlled Rate Freezing, Ultra-Low Temperature Storage) - Growth Outlook & Industry Forecast 2025 To 2035
US Biopreservation Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.75%
2024 Market Size$ 1,200 Million
2025 Market Size$ 1,257 Million
2035 Market Size$ 2,000 Million
Key Players
Thermo Fisher Scientific
Merck KGaA
Sartorius AG
Lonza Group AG
BioLife Solutions
Fresenius Kabi AG
Trends
  • Technological Advancements in Preservation Techniques
  • Increased Demand for Biopharmaceuticals
  • Regulatory Support and Funding Initiatives
Opportunities
  • Expansion of Biobanking Initiatives
  • Growing Focus on Personalized Medicine
  • Increased Awareness of Food Safety Standards
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Construction, BY Application (USD Million)
      1. 4.1.1 Cell and Tissue Culture
      2. 4.1.2 Gene and Drug Therapy
      3. 4.1.3 Clinical Applications
      4. 4.1.4 Regenerative Medicine
    2. 4.2 Construction, BY Product Type (USD Million)
      1. 4.2.1 Biopreservation Media
      2. 4.2.2 Freezers
      3. 4.2.3 Cryogenic Storage Systems
      4. 4.2.4 Accessories
    3. 4.3 Construction, BY End User (USD Million)
      1. 4.3.1 Biotechnology Companies
      2. 4.3.2 Pharmaceutical Companies
      3. 4.3.3 Research Institutions
      4. 4.3.4 Hospitals
      5. 4.3.5 Clinics
    4. 4.4 Construction, BY Storage Type (USD Million)
      1. 4.4.1 Cryopreservation
      2. 4.4.2 Controlled Rate Freezing
      3. 4.4.3 Ultra-Low Temperature Storage
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Construction
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Thermo Fisher Scientific (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Merck KGaA (DE)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Sartorius AG (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Lonza Group AG (CH)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 BioLife Solutions (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Fresenius Kabi AG (DE)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Cytiva (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 NantKwest (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Cryoport Inc. (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY APPLICATION
    3. 6.3 US MARKET ANALYSIS BY PRODUCT TYPE
    4. 6.4 US MARKET ANALYSIS BY END USER
    5. 6.5 US MARKET ANALYSIS BY STORAGE TYPE
    6. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CONSTRUCTION
    9. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION
    11. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION
    12. 6.12 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 CONSTRUCTION, BY PRODUCT TYPE, 2024 (% SHARE)
    15. 6.15 CONSTRUCTION, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 CONSTRUCTION, BY END USER, 2024 (% SHARE)
    17. 6.17 CONSTRUCTION, BY END USER, 2024 TO 2035 (USD Million)
    18. 6.18 CONSTRUCTION, BY STORAGE TYPE, 2024 (% SHARE)
    19. 6.19 CONSTRUCTION, BY STORAGE TYPE, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY PRODUCT TYPE, 2025-2035 (USD Million)
      3. 7.2.3 BY END USER, 2025-2035 (USD Million)
      4. 7.2.4 BY STORAGE TYPE, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Construction Market Segmentation

Construction By Application (USD Million, 2025-2035)

  • Cell and Tissue Culture
  • Gene and Drug Therapy
  • Clinical Applications
  • Regenerative Medicine

Construction By Product Type (USD Million, 2025-2035)

  • Biopreservation Media
  • Freezers
  • Cryogenic Storage Systems
  • Accessories

Construction By End User (USD Million, 2025-2035)

  • Biotechnology Companies
  • US Biopreservation Market Companies
  • Research Institutions
  • Hospitals
  • Clinics

Construction By Storage Type (USD Million, 2025-2035)

  • Cryopreservation
  • Controlled Rate Freezing
  • Ultra-Low Temperature Storage

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.